Involvement of insulin-like growth factor 1 receptor transactivation in endothelin-1-induced signaling in vascular smooth muscle cells

Canadian Journal of Physiology and Pharmacology

Volumn 88, Issue 5, 2010, Pages 501-509

  Bouallegue, Ali ^a,b   Vardatsikos, George ^a,b   Srivastava, Ashok K ^a,b  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

c Src; Cell proliferation; Endothelin 1; Hypertrophy; IGF 1R; PKB; VSMC

Indexed keywords

3 BROMO 5 TERT BUTYL 4 HYDROXYBENZYLIDENEMALONONITRILE; ENDOTHELIN 1; PROTEIN KINASE B; PROTEIN KINASE P60; SOMATOMEDIN C RECEPTOR; PROTEIN BINDING;

PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; ANIMAL; CELL CULTURE; CELL MOTION; CELL PROLIFERATION; CYTOLOGY; GENETICS; HUMAN; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; TRANSCRIPTION INITIATION;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIN-1; HUMANS; MUSCLE, SMOOTH, VASCULAR; PHOSPHORYLATION; PROTEIN BINDING; RECEPTOR, IGF TYPE 1; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION;

EID: 77952934978     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y10-030     Document Type: Review

References (80)

1. Agapitov, A.V., and Haynes, W.G. 2002. Role of endothelin in cardiovascular disease. J. Renin Angiotensin Aldosterone Syst. 3(1): 1-15. doi:10.3317/jraas.2002.001. PMID:11984741.
2. Alonso, D., and Radomski, M.W. 2003. The nitric oxide-endothelin-1 connection. Heart Fail. Rev. 8(1): 107-115. doi:10.1023/A:1022155206928. PMID:12652164.
3. Arai, H., Hori, S., Aramori, I., Ohkubo, H., and Nakanishi, S. 1990. Cloning and expression of a cDNA encoding an endothelin receptor. Nature (Lond.), 348(6303): 730-732. doi:10.1038/348730a0. PMID:2175396. (Pubitemid 120015147)
4. Araki, S., Haneda, M., Togawa, M., and Kikkawa, R. 1997. Endothelin-1 activates c-Jun NH2-terminal kinase in mesangial cells. Kidney Int. 51(3): 631-639. doi:10.1038/ki.1997.92.PMID:9067893. (Pubitemid 27157945)
5. 2-induced PKB phosphorylation in vascular smooth muscle cells. Can. J. Physiol. Pharmacol. 84(7): 777-786. doi:10.1139/Y06-024. PMID:16998541.
6. Azar, Z.M., Mehdi, M.Z., and Srivastava, A.K. 2007. Insulin-like growth factor type-1 receptor transactivation in vasoactive peptide and oxidant-induced signaling pathways in vascular smooth muscle cells. Can. J. Physiol. Pharmacol. 85(1): 105-111. doi:10.1139/Y06-101. PMID:17487250.
7. Bobik, A., Grooms, A., Millar, J.A., Mitchell, A., and Grinpukel, S. 1990. Growth factor activity of endothelin on vascular smooth muscle. Am. J. Physiol. 258(3 Pt 1): C408-C415. PMID: 1690514.
8. Bogoyevitch, M.A., Glennon, P.E., Andersson, M.B., Clerk, A., Lazou, A., Marshall, C.J., et al. 1994. Endothelin-1 and fibroblast growth factors stimulate the mitogen-activated protein kinase signaling cascade in cardiac myocytes. The potential role of the cascade in the integration of two signaling pathways leading to myocyte hypertrophy. J. Biol. Chem. 269(2): 1110-1119. PMID:7507104.
9. Bouallegue, A., Daou, G.B., and Srivastava, A.K. 2007a. Endothelin-1-induced signaling pathways in vascular smooth muscle cells. Curr. Vasc. Pharmacol. 5(1): 45-52. doi:10.2174/157016107779317161. PMID:17266612.
10. Bouallegue, A., Daou, G.B., and Srivastava, A.K. 2007b. Nitric oxide attenuates endothelin-1-induced activation of ERK1/2, PKB, and Pyk2 in vascular smooth muscle cells by a cGMP-dependent pathway. Am. J. Physiol. Heart Circ. Physiol. 293(4): H2072-H2079. doi:10.1152/ajpheart.01097.2006. PMID:17644565.
11. Bouallegue, A., Vardatsikos, G., and Srivastava, A.K. 2009. Role of insulin-like growth factor 1 receptor and c-Src in endothelin-1- and angiotensin II-induced PKB phosphorylation, and hypertrophic and proliferative responses in vascular smooth muscle cells. Can. J. Physiol. Pharmacol. 87(12): 1009-1018. doi:10.1139/Y09-056. PMID:20029537.
12. Chansel, D., Ciroldi, M., Vandermeersch, S., Jackson, L.F., Gomez, A.M., Henrion, D., et al. 2006. Heparin binding EGF is necessary for vasospastic response to endothelin. FASEB J. 20(11): 1936-1938. doi:10.1096/fj.05-5328fje. PMID:16877529. (Pubitemid 44933785)
13. Chen, C.H., Cheng, T.H., Lin, H., Shih, N.L., Chen, Y.L., Chen, Y.S., et al. 2006. Reactive oxygen species generation is involved in epidermal growth factor receptor transactivation through the transient oxidization of Src homology 2-containing tyrosine phosphatase in endothelin-1 signaling pathway in rat cardiac fibroblasts. Mol. Pharmacol. 69(4): 1347-1355. doi:10.1124/mol.105. 017558. PMID:16391241.
14. Chen, Q.W., Edvinsson, L., and Xu, C.B. 2009. Role of ERK/ MAPK in endothelin receptor signaling in human aortic smooth muscle cells. BMC Cell Biol. 10(1): 52. doi:10.1186/1471-2121-10-52. PMID:19575782.
15. Chiloeches, A., Paterson, H.F., Marais, R., Clerk, A., Marshall, C.J., and Sugden, P.H. 1999. Regulation of Ras·GTP loading and Ras-Raf association in neonatal rat ventricular myocytes by G protein-coupled receptor agonists and phorbol ester. Activation of the extracellular signal-regulated kinase cascade by phorbol ester is mediated by Ras. J. Biol. Chem. 274(28): 19762-19770. doi:10.1074/jbc.274.28.19762. PMID:10391918.
16. D'Orléans-Juste, P., Labonté, J., Bkaily, G., Choufani, S., Plante, M., and Honoré, J.C. 2002. Function of the endothelin(B) receptor in cardiovascular physiology and pathophysiology. Pharmacol. Ther. 95(3): 221-238. doi:10.1016/S0163-7258(02)00235-8. PMID:12243796.
17. Daou, G.B., and Srivastava, A.K. 2004. Reactive oxygen species mediate endothelin-1-induced activation of ERK1/2, PKB, and Pyk2 signaling, as well as protein synthesis, in vascular smooth muscle cells. Free Radic. Biol. Med. 37(2): 208-215. doi:10.1016/j.freeradbiomed.2004.04.018. PMID:15203192.
18. Datta, S.R., Brunet, A., and Greenberg, M.E. 1999. Cellular survival: a play in three Akts. Genes Dev. 13(22): 2905-2927. doi:10.1101/gad.13.22.2905. PMID:10579998.
19. Delafontaine, P. 1995. Insulin-like growth factor I and its binding proteins in the cardiovascular system. Cardiovasc. Res. 30(6): 825-834. PMID:8746194.
20. Dong, F., Zhang, X., Wold, L.E., Ren, Q., Zhang, Z., and Ren, J. 2005. Endothelin-1 enhances oxidative stress, cell proliferation and reduces apoptosis in human umbilical vein endothelial cells: role of ETB receptor, NADPH oxidase and caveolin-1. Br. J. Pharmacol. 145(3): 323-333. doi:10.1038/sj.bjp.0706193. PMID:15765100.
21. 2+ transients and contractility in rabbit ventricular myocardium. Life Sci. 62(17-18): 1485-1489. doi:10.1016/S0024-3205(98)00094-0. PMID:9585123.
22. Flamant, M., Tharaux, P.L., Placier, S., Henrion, D., Coffman, T., Chatziantoniou, C., and Dussaule, J.C. 2003. Epidermal growth factor receptor trans-activation mediates the tonic and fibrogenic effects of endothelin in the aortic wall of transgenic mice. FASEB J. 17(2): 327-329. PMID:12475899.
23. Foschi, M., Chari, S., Dunn, M.J., and Sorokin, A. 1997. Biphasic activation of p21ras by endothelin-1 sequentially activates the ERK cascade and phosphatidylinositol 3-kinase. EMBO J. 16(21): 6439-6451. doi:10.1093/emboj/16. 21.6439. PMID: 9351826. (Pubitemid 27483270)
24. Fukami, K. 2002. Structure, regulation, and function of phospholipase C isozymes. J. Biochem. 131(3): 293-299. PMID: 11872156. (Pubitemid 34292818)
25. Gellai, M., Fletcher, T., Pullen, M., and Nambi, P. 1996. Evidence for the existence of endothelin-B receptor subtypes and their physiological roles in the rat. Am. J. Physiol. 271(1 Pt. 2): R254-R261. PMID:8760228.
26. Giorgetti, S., Pelicci, P.G., Pelicci, G., and Van Obberghen, E. 1994. Involvement of Src-homology/collagen (SHC) proteins in signaling through the insulin receptor and the insulin-like-growth-factor-I-receptor. Eur. J. Biochem. 223(1): 195-202. doi:10.1111/j.1432-1033.1994.tb18983.x. PMID:8033892.
27. Görlach, C., Benyó, Z., and Wahl, M. 1998. Endothelin-1-induced contraction in cerebral vessels mediated by phospholipase C/protein kinase C cascade. Kidney Int. Suppl. 67: S224-S225. doi:10.1046/j.1523-1755.1998.06755.x. PMID:9736298.
28. Gutkind, J.S. 1998. Cell growth control by G protein-coupled receptors: from signal transduction to signal integration. Oncogene, 17(11 Reviews): 1331-1342. doi:10.1038/sj.onc.1202186. PMID:9779981.
29. Hashim, S., Li, Y., and Anand-Srivastava, M.B. 2006. Small cytoplasmic domain peptides of natriuretic peptide receptor-C attenuate cell proliferation through Giα protein/MAP kinase/PI3-kinase/AKT pathways. Am. J. Physiol. Heart Circ. Physiol. 291(6): H3144-H3153. doi:10.1152/ajpheart.00327.2006. PMID: 16920814.
30. Hernández-Sánchez, C., Werner, H., Roberts, C.T., Jr., Woo, E.J., Hum, D.W., Rosenthal, S.M., and LeRoith, D. 1997. Differential regulation of insulin-like growth factor-I (IGF-I) receptor gene expression by IGF-I and basic fibroblastic growth factor. J. Biol. Chem. 272(8): 4663-4670. doi:10.1074/jbc.272.8.4663. PMID:9030517.
31. Husain, S., and Abdel-Latif, A.A. 1998. Role of protein kinase C α in endothelin-1 stimulation of cytosolic phospholipase A2 and arachidonic acid release in cultured cat iris sphincter smooth muscle cells. Biochim. Biophys. Acta, 1392(1): 127-144. PMID:9593858.
32. Iglarz, M., and Schiffrin, E.L. 2003. Role of endothelin-1 in hypertension. Curr. Hypertens. Rep. 5(2): 144-148. doi:10.1007/s11906-003-0071- 4. PMID:12642014.
33. Kodama, H., Fukuda, K., Takahashi, T., Sano, M., Kato, T., Tahara, S., et al. 2002. Role of EGF Receptor and Pyk2 in endothelin-1-induced ERK activation in rat cardiomyocytes. J. Mol. Cell. Cardiol. 34(2): 139-150. doi:10.1006/jmcc.2001.1496. PMID:11851354.
34. Kodama, H., Fukuda, K., Takahashi, E., Tahara, S., Tomita, Y., Ieda, M., et al. 2003. Selective involvement of p130Cas/Crk/ Pyk2/c-Src in endothelin-1-induced JNK activation. Hypertension, 41(6): 1372-1379. doi:10.1161/01.HYP.0000069698.11814.F4. PMID:12719447. (Pubitemid 36706092)
35. Kopetz, E.S., Nelson, J.B., and Carducci, M.A. 2002. Endothelin-1 as a target for therapeutic intervention in prostate cancer. Invest. New Drugs, 20(2): 173-182. doi:10.1023/A:1015630513908. PMID:12099577.
36. Lee, S.R., Kwon, K.S., Kim, S.R., and Rhee, S.G. 1998. Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor. J. Biol. Chem. 273(25): 15366-15372. doi:10.1074/jbc.273.25.15366. PMID: 9624118.
37. Leevers, S.J., Vanhaesebroeck, B., and Waterfield, M.D. 1999. Signalling through phosphoinositide 3-kinases: the lipids take centre stage. Curr. Opin. Cell Biol. 11(2): 219-225. doi:10.1016/S0955-0674(99)80029-5. PMID:10209156.
38. LeRoith, D., Werner, H., Beitner-Johnson, D., and Roberts, C.T., Jr. 1995. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr. Rev. 16(2): 143-163. PMID: 7540132.
39. Li, F., and Malik, K.U. 2005. Angiotensin II-induced Akt activation through the epidermal growth factor receptor in vascular smooth muscle cells is mediated by phospholipid metabolites derived by activation of phospholipase D. J. Pharmacol. Exp. Ther. 312(3): 1043-1054. doi:10.1124/jpet.104.076588. PMID: 15525798.
40. Li, Y., Hashim, S., and Anand-Srivastava, M.B. 2006. Intracellular peptides of natriuretic peptide receptor-C inhibit vascular hypertrophy via Gqα/MAP kinase signaling pathways. Cardiovasc. Res. 72(3): 464-472. doi:10.1016/j.cardiores.2006.08.012. PMID:17007826.
41. Lim, H.J., Park, H.Y., Ko, Y.G., Lee, S.H., Cho, S.Y., Lee, E.J., et al. 2004. Dominant negative insulin-like growth factor-1 receptor inhibits neointimal formation through suppression of vascular smooth muscle cell migration and proliferation, and induction of apoptosis. Biochem. Biophys. Res. Commun. 325(3): 1106-1114. doi:10.1016/j.bbrc.2004.10.175. PMID:15541402.
42. McNair, L.L., Salamanca, D.A., and Khalil, R.A. 2004. Endothelin-1 promotes Ca2+ antagonist-insensitive coronary smooth muscle contraction via activation of epsilon-protein kinase C. Hypertension, 43(4): 897-904. doi:10.1161/01.HYP.0000118520.92686.3b. PMID:14981072.
43. Mehdi, M.Z., Pandey, N.R., Pandey, S.K., and Srivastava, A.K. 2005. H2O2-induced phosphorylation of ERK1/2 and PKB requires tyrosine kinase activity of insulin receptor and c-Src. Antioxid. Redox Signal. 7(7-8): 1014-1020. doi:10.1089/ars.2005.7.1014. PMID:15998256.
44. Meng, T.C., Fukada, T., and Tonks, N.K. 2002. Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol. Cell, 9(2): 387-399. doi:10.1016/S1097-2765(02)00445-8. PMID:11864611.
45. Meng, D., Shi, X., Jiang, B.H., and Fang, J. 2007. Insulin-like growth factor-I (IGF-I) induces epidermal growth factor receptor transactivation and cell proliferation through reactive oxygen species. Free Radic. Biol. Med. 42(11): 1651-1660. doi:10.1016/j.freeradbiomed.2007.01.037. PMID:17462533.
46. Mulder, P., Richard, V., Derumeaux, G., Hogie, M., Henry, J.P., Lallemand, F., et al. 1997. Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling. Circulation, 96(6): 1976-1982. PMID:9323089. (Pubitemid 27400761)
47. Nguyen, T.T., Cao, N., Short, J.L., and White, P.J. 2006. Intravenous insulin-like growth factor-I receptor antisense treatment reduces angiotensin receptor expression and function in spontaneously hypertensive rats. J. Pharmacol. Exp. Ther. 318(3): 1171-1177. doi:10.1124/jpet.106.103655. PMID:16751253.
48. Oldham, S., and Hafen, E. 2003. Insulin/IGF and target of rapamycin signaling: a TOR de force in growth control. Trends Cell Biol. 13(2): 79-85. doi:10.1016/S0962-8924(02)00042-9. PMID: 12559758. (Pubitemid 36135889)
49. Peterson, J.E., Kulik, G., Jelinek, T., Reuter, C.W., Shannon, J.A., and Weber, M.J. 1996. Src phosphorylates the insulin-like growth factor type I receptor on the autophosphorylation sites: requirement for transformation by src. J. Biol. Chem. 271(49): 31562-31571. doi:10.1074/jbc.271.49.31562. PMID:8940173.
50. Pham, F.H., Cole, S.M., and Clerk, A. 2001. Regulation of cardiac myocyte protein synthesis through phosphatidylinositol 3′ kinase and protein kinase B. Adv. Enzyme Regul. 41(1): 73-86. doi:10.1016/S0065-2571(00)00007-8. PMID:11384738.
51. Pierce, K.L., Premont, R.T., and Lefkowitz, R.J. 2002. Seven-transmembrane receptors. Nat. Rev. Mol. Cell Biol. 3(9): 639-650. doi:10.1038/nrm908. PMID:12209124.
52. Rabelink, T.J., Kaasjager, K.A., Boer, P., Stroes, E.G., Braam, B., and Koomans, H.A. 1994. Effects of endothelin-1 on renal function in humans: implications for physiology and pathophysiology. Kidney Int. 46(2): 376-381. doi:10.1038/ki.1994.284. PMID:7967349. (Pubitemid 24253043)
53. Rhee, S.G. 2001. Regulation of phosphoinositide-specific phospholipase C. Annu. Rev. Biochem. 70(1): 281-312. doi:10.1146/annurev.biochem.70.1.281. PMID:11395409.
54. Rhee, S.G. 2006. Cell signaling. H2O2, a necessary evil for cell signaling. Science (Washington, D.C.), 312(5782): 1882-1883. doi:10.1126/science.1130481. PMID:16809515.
55. Robin, P., Boulven, I., Desmyter, C., Harbon, S., and Leiber, D. 2002. ET-1 stimulates ERK signaling pathway through sequential activation of PKC and Src in rat myometrial cells. Am. J. Physiol. Cell Physiol. 283(1): C251-C260. PMID:12055094.
56. Rosen, B., Barg, J., and Zimlichman, R. 1999. The effects of angiotensin II, endothelin-1, and protein kinase C inhibitor on DNA synthesis and intracellular calcium mobilization in vascular smooth muscle cells from young normotensive and spontaneously hypertensive rats. Am. J. Hypertens. 12(1-2): 1243-1251. doi:10.1016/S0895-7061(99)00158-2. PMID:10619588.
57. Rozakis-Adcock, M., McGlade, J., Mbamalu, G., Pelicci, G., Daly, R., Li, W., et al. 1992. Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature (Lond.), 360(6405): 689-692. doi:10.1038/360689a0. PMID:1465135. (Pubitemid 23007687)
58. Sakurai, T., Yanagisawa, M., Takuwa, Y., Miyazaki, H., Kimura, S., Goto, K., and Masaki, T. 1990. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature (Lond.), 348(6303): 732-735. doi:10.1038/348732a0. PMID:2175397. (Pubitemid 120015148)
59. Schiffrin, E.L. 1995. Endothelin: potential role in hypertension and vascular hypertrophy. Hypertension, 25(6): 1135-1143. PMID: 7768553.
60. Schiffrin, E.L. 2001. Role of endothelin-1 in hypertension and vascular disease. Am. J. Hypertens. 14(6 Pt. 2): 83S-89S. doi:10. 1016/S0895-7061(01) 02074-X. PMID:11411770.
61. Schmidt, H.H., and Walter, U. 1994. NO at work. Cell, 78(6): 919-925. doi:10.1016/0092-8674(94)90267-4. PMID:7923361.
62. Shi-Wen, X., Chen, Y., Denton, C.P., Eastwood, M., Renzoni, E.A., Bou-Gharios, G., et al. 2004. Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/ phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts. Mol. Biol. Cell, 15(6): 2707-2719. doi:10.1091/mbc.E03-12-0902. PMID:15047866.
63. Song, G., Ouyang, G., and Bao, S. 2005. The activation of Akt/PKB signaling pathway and cell survival. J. Cell. Mol. Med. 9(1): 59-71. doi:10.1111/j.1582-4934.2005.tb00337.x. PMID: 15784165.
64. Sorokin, A., Kozlowski, P., Graves, L., and Philip, A. 2001. Protein-tyrosine kinase Pyk2 mediates endothelin-induced p38 MAPK activation in glomerular mesangial cells. J. Biol. Chem. 276(24): 21521-21528. doi:10.1074/jbc.M008869200. PMID: 11278444.
65. Sugden, P.H. 2003. An overview of endothelin signaling in the cardiac myocyte. J. Mol. Cell. Cardiol. 35(8): 871-886. doi:10.1016/S0022-2828(03)00153- 6. PMID:12878473.
66. Sumitomo, M., Milowsky, M.I., Shen, R., Navarro, D., Dai, J., Asano, T., et al. 2001. Neutral endopeptidase inhibits neuropeptide-mediated transactivation of the insulin-like growth factor receptor - Akt cell survival pathway. Cancer Res. 61(8): 3294-3298. PMID:11309283. (Pubitemid 32695016)
67. Touyz, R.M., Yao, G., Viel, E., Amiri, F., and Schiffrin, E.L. 2004. Angiotensin II and endothelin-1 regulate MAP kinases through different redox-dependent mechanisms in human vascular smooth muscle cells. J. Hypertens. 22(6): 1141-1149. doi:10.1097/00004872-200406000-00015. PMID:15167449. (Pubitemid 38721006)
68. Tsuruzoe, K., Emkey, R., Kriauciunas, K.M., Ueki, K., and Kahn, C.R. 2001. Insulin receptor substrate 3 (IRS-3) and IRS-4 impair IRS-1- and IRS-2-mediated signaling. Mol. Cell. Biol. 21(1): 26-38. doi:10.1128/MCB.21.1. 26-38.2001. PMID:11113178.
69. Ushio-Fukai, M., Griendling, K.K., Becker, P.L., Hilenski, L., Halleran, S., and Alexander, R.W. 2001. Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 21(4): 489-495. PMID:11304462.
70. Vardatsikos, G., Sahu, A., and Srivastava, A.K. 2009. The insulin-like growth factor family: molecular mechanisms, redox regulation, and clinical implications. Antioxid. Redox Signal. 11(5): 1165-1190. doi:10.1089/ars.2008. 2161. PMID:19014342.
71. White, M.F. 2002. IRS proteins and the common path to diabetes. Am. J. Physiol. Endocrinol. Metab. 283(3): E413-E422. PMID: 12169433.
72. Whiteman, E.L., Cho, H., and Birnbaum, M.J. 2002. Role of Akt/protein kinase B in metabolism. Trends Endocrinol. Metab. 13(10): 444-451. doi:10.1016/S1043-2760(02)00662-8. PMID: 12431841.
73. Yamauchi, J., Miyamoto, Y., Kokubu, H., Nishii, H., Okamoto, M., Sugawara, Y., et al. 2002. Endothelin suppresses cell migration via the JNK signaling pathway in a manner dependent upon Src kinase, Rac1, and Cdc42. FEBS Lett. 527(1-3): 284-288. doi:10.1016/S0014-5793(02)03231-3. PMID:12220675. (Pubitemid 35253880)
74. Yamboliev, I.A., Hruby, A., and Gerthoffer, W.T. 1998. Endothelin-1 activates MAP kinases and c-Jun in pulmonary artery smooth muscle. Pulm. Pharmacol. Ther. 11(2-3): 205-208. doi:10.1006/pupt.1998.0139. PMID:9918757.
75. Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., et al. 1988. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature (Lond.), 332(6163): 411-415. doi:10.1038/332411a0. PMID:2451132. (Pubitemid 18090241)
76. Yoshizumi, M., Kim, S., Kagami, S., Hamaguchi, A., Tsuchiya, K., Houchi, H., et al. 1998. Effect of endothelin-1 (1-31) on extracellular signal-regulated kinase and proliferation of human coronary artery smooth muscle cells. Br. J. Pharmacol. 125(5): 1019-1027. doi:10.1038/sj.bjp.0702141. PMID:9846640.
77. Yue, T.L., Gu, J.L., Wang, C., Reith, A.D., Lee, J.C., Mirabile, R.C., et al. 2000. Extracellular signal-regulated kinase plays an essential role in hypertrophic agonists, endothelin-1 and phenylephrine-induced cardiomyocyte hypertrophy. J. Biol. Chem. 275(48): 37895-37901. doi:10.1074/jbc.M007037200. PMID:10984495.
78. Zahradka, P., Litchie, B., Storie, B., and Helwer, G. 2004. Transactivation of the insulin-like growth factor-I receptor by angiotensin II mediates downstream signaling from the angiotensin II type 1 receptor to phosphatidylinositol 3-kinase. Endocrinology, 145(6): 2978-2987. doi:10.1210/en.2004-0029. PMID:14976148. (Pubitemid 38686247)
79. Zheng, B., and Clemmons, D.R. 1998. Blocking ligand occupancy of the αVβ3 integrin inhibits insulin-like growth factor I signaling in vascular smooth muscle cells. Proc. Natl. Acad. Sci. U.S.A. 95(19): 11217-11222. doi:10.1073/pnas.95.19.11217. PMID:9736716.
80. Zheng, H.Z., An, G.S., Nie, S.H., Tang, C.S., Liu, N.K., and Wang, S.H. 1998. Inhibition of signal transduction pathways of endothelin-1-induced proliferation of vascular smooth muscle cells by nitric oxide. Sheng Li Xue Bao, 50(4): 379-384. PMID: 11324546. [In Chinese.]